SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling could be on the horizon following reports of potential executive action. The community is actively discussing the implications of this policy change, particularly how it might trigger a short squeeze and impact the broader cannabis sector. Some are also pointing to Tilray's 'Liquid Diamond' vapes as a potential catalyst.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending after its earnings report triggered a volatile swing, initially rising on strong AI chip sales and guidance, but then sharply declining during the earnings call. Community discussion revolves around potential profit-taking, concerns about non-AI revenue, and the impact of comments made during the call. Despite strong fundamentals, the stock's reaction highlights the market's sensitivity to AI-related news and broader sector trends.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its cultural significance within the cannabis space and its positioning as a "culture coin" on the Solana network. Discussions also highlight potential synergies with broader cannabis reform and related stocks like $TLRY, with community members emphasizing the project's long-term vision.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is gaining significant traction, fueled by community enthusiasm and the narrative of being the next big meme on Ethereum. The community highlights its strong momentum, steady buying pressure, and potential as a key player in the ETH ecosystem. Some believe $YEE is on the verge of a major breakout, drawing comparisons to past meme coin successes.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as community members discuss its potential as a high-throughput Layer-1 blockchain for global finance. Community discussion highlights its compliance-first architecture and potential to bridge traditional finance and crypto. Some view Keeta as a compelling infrastructure bet, emphasizing its role in facilitating settlement, institutional flows, and cross-chain routing.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a potential bidding war with Paramount for Warner Bros. Discovery, with some investors hoping Netflix will abandon the deal and collect a $2.8 billion breakup fee, potentially boosting the stock; community chatter revolves around the deal's implications, regulatory hurdles, and potential impact on Netflix's financials and content strategy.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors digest better-than-expected earnings and revenue, alongside news of the CEO's upcoming departure which some see as a potential catalyst for innovation. Community discussions revolve around the company's guidance, share buybacks, and the potential for analyst upgrades. Bullish sentiment seems to be building on the prospect of new leadership and continued growth, particularly in the international market.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL is trending following news of a national retail distribution agreement with Walmart, leading to a surge in pre-market activity and attracting attention from momentum traders. Community discussions revolve around the potential for a short squeeze and further upward movement, while some traders are wary of potential pullbacks. The stock's thin float and recent high volatility are also key talking points among investors.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is trending as the community discusses its potential within the aerospace sector, drawing comparisons to SpaceX's valuation and future prospects, with many anticipating significant growth pending successful satellite launches and commercialization in 2026. Community members are also weighing recent insider selling against the overall bullish sentiment, while closely monitoring developments related to launch dates and government contracts. Some traders are noting technical indicators and discussing potential short squeezes, further fueling the stock's volatile movements.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox ($RBLX) is trending amid mixed sentiment, with analysts updating ratings and price targets. The community is actively discussing Roblox's safety measures and potential legal liabilities, especially in light of recent bans and concerns over user demographics. Many traders are weighing the potential for short-term bounces against long-term concerns about the company's business model and profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<h3>Agreement includes minimum annual order commitments totalling approximately USD $1.3 million</h3>MELBOURNE, Australia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science based innovator in gel based oral delivery technologies, today announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management Co. Ltd. (“Mana”) under which Mana will distribute consumer nutritional products within China using Gelteq’s proprietary gel formulation. The agreement represents a significant step forward in expanding Gelteq’s nutritional product portfolio in China.Mana is a well-established distributor of healthcare and wellness products in China with a strong digital presence and a network of offline retail sales channels. This infrastructure provides an existing platform to introduce Gelteq’s nutritional formulations to a new and broad consumer base across the country.Under the agreement, Mana will promote, market, and sell a nutritional formulation primarily focused on sugar lowering across China through its multichannel healthcare network. The agreement also includes minimum annual order volumes during its three-year term which Gelteq expects to derive a minimum revenue of approximately USD $1.3 million during the term of the agreement.The agreement accelerates Gelteq’s strategy to expand its proprietary nutritional formulations in China, one of the world’s largest and fastest growing wellness and functional nutrition markets. The agreement also establishes a pathway to introduce additional nutritional products that incorporate Gelteq’s proprietary technology.“Our agreement with Mana Health represents a significant milestone in expanding nutritional products featuring Gelteq’s technology in China,” said Nathan Givoni, Chief Executive Officer of Gelteq. “By securing multi-year minimum commitments from distributors such as Mana, we seek to generate predictable revenue and advance the adoption of our platform in one of the most strategically important markets for nutritional products globally.”The agreement builds upon the recent launch of Gelteq’s sports performance range across Asia and reflects increased demand for Gelteq’s innovative gel based technology. The Company’s expanding presence in Asia demonstrates both market readiness and consumer appetite for scientifically developed delivery formats that enhance convenience, taste, and functionality.“The momentum we are seeing across Asia highlights the versatility of our gel platform and the readiness of our regional partners to distribute our science driven solutions,” Mr. Givoni said. “We are actively pursuing additional partnerships of a similar nature in the near term.”About Gelteq Ltd.Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a biotechnology company that has developed a novel drug delivery platform in an ingestible gel form. Gelteq specializes in the formulation, development and manufacturing of gel products for licensed partners across pharmaceutical, consumer health and animal health markets. The proprietary formulation technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing. For more information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=tBon1Mk31lSV1X44QsCUylVsZfOkctA_mNtrMtNPGzSYJrwsiPvSN-4INpzpMW0wLJBmz2S5QLpoj-Y2d-Y4_w==">www.gelteq.com</a>.Gelteq Contact: Investor Relations Matt Kreps, Darrow Associates IR +1-214-597-8200 mkreps@darrowir.comForward-Looking StatementsCertain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained herein are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on November 17, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/NewsRoom/AttachmentNg/178e1a9c-f21e-4691-add7-b1398d96f7a6"><img style="height:auto;" src="https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg" alt="Primary Logo" width="150" height="22"></a>Source: Gelteq LimitedReleased December 9, 2025Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

Gelteq signed a three-year agreement with Shenzhen Mana Health Management to distribute its sugar-lowering nutritional products in China, guaranteeing approximately $1.3 million in minimum revenue.

Others

VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces it has signed an offer to acquire a surveying firm headquartered in the Mountain West/Rocky Mountain region of the US with existing licensing to operate in multiple states. The potential acquisition enhances ZenaTech’s presence in the region and capacity to provide drone-enabled advanced land surveying as well as drone services for modern crop and livestock management, wildfire management, and land stewardship.“Expanding our Drone as a Service footprint across the Mountain West/Rocky Mountain region through this potential acquisition will open significant opportunities to support builders and the construction industry as well as farmers, ranchers, and government with cutting-edge, technology-driven drone solutions,” said Shaun Passley, Ph.D., ZenaTech CEO. “Drones are transforming how land is managed across this region by providing powerful solutions for rangeland and livestock monitoring, precision farming, wildfire detection and response, and large-scale environmental and forestry assessment bringing unmatched efficiency, safety, and real-time insight to managing and sustaining vast and rugged landscapes.”The potential acquisition target offers a full range of surveying services supporting boundary, topographic, land title surveys and construction projects. The firm’s leadership is licensed to operate and serve clients in multiple states, bringing regional expertise and relationships in Mountain West/Rocky Mountain jurisdictions.Currently, ZenaTech has completed 14 global surveying company acquisitions toward its goal of acquiring and establishing 25 DaaS locations by the end of Q2, 2026. The DaaS business model is designed to offer business and government clients flexible, on-demand, or subscription-based access to drone services such as surveying, inspection, maintenance, power washing, inventory management, and precision agriculture, without the capital costs or operational burdens of ownership. By acquiring established, profitable low-tech service companies ready for drone innovation, ZenaTech is building a global, multi-service DaaS network anchored by existing customers and recurring revenue.About ZenaTech<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=HGXECffYWcysbswKG3rAwlzFoBBcAbP2_2MqScmhf5ikZ12srdRIWjyY9aHXbez2n_SpVC6K_cCcynJok5NXng==">ZenaTech</a> (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company specializing in AI drone, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=QM7ZQ0vIXWDzXFxtmXKrHkkfTZzipikBtbJQ1J0SkkI3VWQxH68w33IIRavaoQc5twBPJ07NwF6EWk9FNz-8Lv0PqhZ8OpA8f5yu7TMQoxk=">Drone as a Service</a> (DaaS), enterprise SaaS and Quantum Computing solutions for mission-critical business applications. Since 2017, the Company has leveraged its software development expertise and grown its drone design and manufacturing capabilities through ZenaDrone, to innovate and improve customer inspection, monitoring, maintenance, security, compliance, and surveying processes. With enterprise software customers using branded solutions across law enforcement, government, and industrial sectors, and drones being implemented across multiple commercial, agricultural and defense sectors, ZenaTech’s portfolio of solutions help drive exceptional operational efficiencies, precision, safety, and cost savings. The Company operates through offices in North America, Europe, Taiwan, and UAE, and is growing its global DaaS business and network of locations through acquisitions.About ZenaDrone<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Z7AkmeHeXgBDhoXnkIcLjruWexRR6Ux6lD02uxiWnIBRJntWREt5v9Q_LwqKyVD95DE7KajoNt4W8c0dmkDm4g==">ZenaDrone</a>, a wholly owned subsidiary of ZenaTech, develops and manufactures autonomous business drone solutions that can incorporate machine learning software, AI, predictive modeling, Quantum Computing, and other software and hardware innovations. Created to revolutionize the hemp farming sector, its specialization has grown to multifunctional drone solutions for industrial surveillance, monitoring, inspection, tracking, process automation, and defense applications. Currently, the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Z7AkmeHeXgBDhoXnkIcLjj-UlX3rCSACBHcxfmeoXumjiRqF_QjVVSTuMktLTwRs6FgcACi9eqARPqqBio3oXuF8VYXGXmyO2Qzn3-sCGms5c15PcW1ZE761EAXFQdgt">ZenaDrone 1000</a> drone is used for crop management applications in agriculture and critical field cargo applications in the defense sector, the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=2I6mD14mOsMmqeaUOChu-2V2n1A436_MjzWrxhXdZffppm1dW_IBHKbn6WHlvQLMUb1O1JPca5kwPtogHXEajlC82RwTTG8byMYfVYEEqhcWvKFjgI2T0-y_a1JDwAXJ">IQ Nano</a> indoor drone is used for inventory management and security in the warehouse and logistics sectors, and the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=tZOI1ASg6NzzanMa0ZsSZxlx8sKOsnFz8WspUD_KfNcZqOOgdFC4_6sqnFqJQo244YQ4Z9e9EWw_vhH9GG9VZi9_YurCoNHPB1UClziIAUs8EX0V-bUwrKsbtHcTFy9h">IQ Square</a> is an outdoor drone designed for land surveys and inspections use in commercial and defense sectors.Contacts for more information:Company, Investors, and Media:Linda MontgomeryZenaTech312-241-1415<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=21jgCSFefT17--eexUHz8R3sn_5MYoqnuu2TGcA2Urg604z2-ycVsVxretJZCCHybQQEHzZaFC9noh1_guTed8ae70XJ8wk4dpZSsRd0rzc=">investors@zenatech.com</a>Investors:Michael MasonCORE IR<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=21jgCSFefT17--eexUHz8R3sn_5MYoqnuu2TGcA2UrgaG2VaN4jklp0yoIIW2msNj2aPalJob96ETKEMBiY7EPxNGoh_Vhi0daqe-gKMHFg=">investors@zenatech.com</a>Safe HarborThis press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. &nbsp;Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity;&nbsp;ZenaTech's ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000 and IQ Nano;&nbsp;ZenaTech’s anticipated cash needs and it’s needs for additional financing;&nbsp;ZenaTech’s intention to grow the business and its operations and execution risk;&nbsp;expectations with respect to future operations and costs;&nbsp;the volatility of stock prices and market conditions in the industries in which ZenaTech operates;&nbsp;political, economic, environmental, tax, security, and other risks associated with operating in emerging markets;&nbsp;regulatory risks;&nbsp;unfavorable publicity or consumer perception;&nbsp;difficulty in forecasting industry trends;&nbsp;the ability to hire key personnel;&nbsp;the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months;&nbsp;ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments;&nbsp;investment capital and market share; the ability to complete any contemplated acquisitions;&nbsp;changes in the target markets;&nbsp;market uncertainty;&nbsp;ability to access additional capital, including through the listing of its securities in various jurisdictions;&nbsp;management of growth (plans and timing for expansion);&nbsp;patent infringement;&nbsp;litigation;&nbsp;applicable laws, regulations, and any amendmentsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

ZenaTech Signs Offer to Acquire a Surveying Firm in the US West Expanding Drone as a Service Footprint to Serve Precision Agriculture, Ranching and Wildfire Management

ZenaTech plans to acquire a Mountain West surveying firm to expand its drone services footprint and DaaS network.

MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq’s technology can enhance the oral delivery of oil-soluble and poorly soluble drugs.Across two complementary preclinical studies, the results showed a more rapid absorption of an oil soluble compound in Gelteq’s gel base compared to an existing FDA approved reference product, with a 300 percent increase in bioavailability across the first hour. High bioavailability in the first hour is critical for rapid onset of action.Further results demonstrated that the oil soluble compound wasn’t just more rapidly absorbed in Gelteq’s gel base, but the overall absorption was also improved. Over 24 hours, the absorption was improved by more than 20 percent overall compared to an existing FDA approved reference product. These findings further illustrate that Gelteq’s gel matrix can support the delivery of lipophilic compounds whilst moderating the need for high levels of emulsifiers.The study results also demonstrate that Gelteq’s platform enables controlled movement through the digestive system, targeted release, and effective absorption while maintaining full clearance of both the active pharmaceutical ingredients (API) and the gel material itself.The GI transit evaluation demonstrated that the gel disperses the active ingredient uniformly along the small intestine. This extended distribution behaviour supports improved absorption through both mucoadhesive interactions and the presentation of the drug across a larger intestinal surface area.The studies also showed that the gel can be formulated to allow efficient transit and rapid early absorption of the API. The gel’s structural matrix dispersed and cleared effectively to the large intestine, reinforcing the platform’s safety and compatibility with oral administration.These combined findings highlight Gelteq’s potential to provide a new and more versatile alternative to existing oral delivery approaches for oil-soluble and poorly soluble drugs.With more than 40 percent of approved drugs and up to 90 percent of developmental candidates affected by poor solubility and bioavailability, the industry continues to invest billions of dollars1 annually in new technologies to overcome these issues. Gelteq’s platform offers a streamlined solution that may reduce developmental burdens, enhance bioavailability, and open pathways to revive previously shelved or challenging molecules.Therapeutic areas most likely to benefit from Gelteq’s gel-based delivery system include neurology, inflammation and pain management, hormonal therapies, cardiovascular medicine, nutraceuticals, weight management, oncology and veterinary health - categories where lipid-based or poorly soluble APIs are common and where improved absorption could meaningfully enhance clinical performance.By enabling more consistent absorption, targeted delivery, reduced excipient reliance, and strong safety characteristics, the gel-based delivery system positions Gelteq as a valuable development partner for pharmaceutical and nutraceutical companies seeking to reformulate existing assets or address complex formulation challenges in their pipelines.About Gelteq Ltd.Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a biotechnology company that has developed a novel drug delivery platform in an ingestible gel form. Gelteq specializes in the formulation, development and manufacturing of gel products for licensed partners across pharmaceutical, consumer health and animal health markets. The proprietary formulation technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing. For more information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=8TzpuxlNIZnf90MC0gt__SjBKV07HnilBr_4YjEopptBEfiLyv9wJKW-5OUbN7TXIYfw0WSX-OqI0wqEzv-2HQ==">www.gelteq.com</a>.Gelteq Contact: Investor Relations Matt Kreps, Darrow Associates IR +1-214-597-8200 mkreps@darrowir.comForward-Looking StatementsCertain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained herein are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on November 17, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof._________________________ 1 Solubility Enhancement Excipients Market Size 2025-2032<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/NewsRoom/AttachmentNg/178e1a9c-f21e-4691-add7-b1398d96f7a6"><img style="height:auto;" src="https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg" alt="Primary Logo" width="150" height="22"></a>Source: Gelteq LimitedReleased December 5, 2025Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Gelteq announced preclinical results demonstrating its proprietary gel platform significantly improved the absorption and bioavailability of poorly soluble drugs.

MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at the&nbsp;Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq’s growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies. This quarter’s event highlights MicroCap companies with compelling value propositions and near-term growth drivers, offering investors a focused platform for discovery.Mr. Givoni will be presenting on December 9 at 4:00 PM ET, together with hosting one-on-one meetings with Institutional and High Net Worth (HNW) investors on December 10th. To request a one-on-one meeting, please reach out to the conference contact or Gelteq investor relations, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=auqwme3YdpYiaBjxXGSAWDOcJPN_1fxIx_B_lJO2Ot1jQ93GVjfRsma0DFbuOrsbln1KcIa5u-foTiXxN1emquUFqcWnPDmAQHbPm7PQPG4=">mkreps@darrowir.com</a>.Event Details:<ul><li>Event: Q4 Investor Summit</li><li>Presentation Date &amp; Time: December 9 | 4:00 PM ET</li><li>Request Access: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investorsummitgroup.com/">https://investorsummitgroup.com/</a>&nbsp;&nbsp;</li><li>Conference Contact: For more information, please contact: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:fred@investorsummitgroup.com">fred@investorsummitgroup.com</a></li></ul>About Gelteq Ltd. Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a clinical and science-based company dedicated to developing and commercialising gel-based oral delivery solutions for prescription drugs, nutraceuticals, pet care, sports nutrition, and other applications. Gelteq’s proprietary formulation technology aims to address challenges associated with conventional drug delivery, including taste masking, swallowing difficulties, and precision dosing. For more information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=l1iFXs67cLJoJ6QWLjqPxC7Jfn9AwDiwSZM4VDbHDQBTCOryjUdIVFugvfQpltStl5L8j7NSuSGTKmuoZ0GqeQ==">www.gelteq.com</a>.Gelteq Contact: Investor Relations Matt Kreps, Darrow Associates IR +1-214-597-8200 <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=auqwme3YdpYiaBjxXGSAWGoTfcdGe6pByXXUHGMOlq9DGCxmWi1tAwlsChGi4FKBjiTkRo98Jt_YcGboxWlDTkdgw1O-ohPRL-Moea_0OT0=">mkreps@darrowir.com</a>Forward-Looking Statements Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained herein are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on November 17, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/NewsRoom/AttachmentNg/178e1a9c-f21e-4691-add7-b1398d96f7a6"><img style="height:auto;" src="https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg" alt="Primary Logo" width="150" height="22"></a>Source: Gelteq LimitedReleased December 2, 2025Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Gelteq to Present at Investor Summit Virtual on December 9, 2025

Gelteq Limited CEO, Nathan Givoni, is scheduled to present updates on the company's growth strategy and market positioning at the Q4 Investor Summit Virtual on December 9, 2025.

VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces the acquisition of Casado Design Ltd., a survey and design company located in the South West of England with a strong reputation and expertise in 3D modeling and scanning services for tower and infrastructure building in the telecom sector. This acquisition marks the entry of Drone as a Service to the UK and the company’s expansion into telecom infrastructure, an area experiencing new investment and transformation in the UK and across Europe.“Acquiring Casado Design is an important milestone expanding our Drone as a Service footprint to the UK and to the doorstep of Europe. Importantly, it adds a new vertical to our network in a rapidly growing sector,” said Shaun Passley, Ph.D., ZenaTech CEO. “Their strong foothold in telecom infrastructure perfectly complements our AI-driven drone capabilities enabling delivery of safer, faster, and more cost-effective telecom infrastructure building. As telecom networks undergo unprecedented transformation with 5G infrastructure modernization and greater cost controls, the integration of advanced, drone-based 3D modeling and scanning solutions positions us delivering faster and more precise tower infrastructure solutions while enhancing safety standards.”Founded in 2010 in Weston-super-Mare near Bristol, Casado Design has long-standing relationships with major telecom operators and tower clients across England. It delivers comprehensive and precise design solutions supporting the full lifecycle of telecom infrastructure, from building and upgrading to decommissioning. This includes advanced digital twins and building information modeling (BIM) that streamline infrastructure management. Looking ahead, the company plans to expand Casado’s capabilities into drone-enabled rust remediation and spray-painting services to meet evolving tower maintenance needs.In the UK, drone-enabled tower design and maintenance is gaining momentum as telecom consolidation, led by the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=XKRCAb0KpDupnY7MTk_vQvQ2vqlwsOJCgSYYabe7a8jBDILu3GSuauGFKqCI7S3D6C8VTnGEKQEtkM6qPKM87kVwUdshUDzfVL_Alb-TavRWQzgGrLrTLNWYJQYzAeh0KQLW9VRtOubPNGIgxja8AW6-TQH-FuSIjmEoXj0hhO8aCGXWFgBSkiZDjfCxvCaT">Vodafone–Three merger</a> and an £11 billion commitment over the next decade for 5G rollout commitments, are pushing operators and tower companies to modernize infrastructure faster, more safely, and at lower cost. Large tower companies now require scalable, data-rich inspection and design workflows, making drones an attractive solution for rapid surveys, digital twins, and predictive maintenance. The same forces are unfolding across Europe, creating a broader regional tailwind for drone-based tower services.ZenaTech’s Drone as a Service offering is designed to provide business and government clients with flexible and on-demand or subscription-based access to drone services for surveying, inspection, maintenance, power washing, inventory management, precision agriculture, and other services, without the capital costs or operational burdens of ownership. By&nbsp;acquiring&nbsp;established and profitable legacy service companies ready for drone innovation, ZenaTech is building a global, multi-service DaaS network anchored by existing customers and recurring revenue.&nbsp;About ZenaTech<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=y6szSW5eBWTtddb3WlFRilJYSlSurCVjUijXiJHmDS8cDSpMmDCR1dq1O0maJmxdvwWe-8nBto8Ttan3E-FZ_Q==">ZenaTech</a> (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company specializing in AI drone, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Vv3SrVQpEtHSx9fWnqFc4ehjTeyrDGM4Bbd3LaK7t6f6s5BFxrKu62PD4I_fXSY0uk9eSIaU2j5nvnSYdRTKYFvwvCsDTyk_qROlLofDee0=">Drone as a Service</a> (DaaS), enterprise SaaS and Quantum Computing solutions for mission-critical business applications. Since 2017, the Company has leveraged its software development expertise and grown its drone design and manufacturing capabilities through ZenaDrone, to innovate and improve customer inspection, monitoring, safety, security, compliance, and surveying processes. With enterprise software customers using branded solutions in law enforcement, government, and industrial sectors, and drones being implemented in these plus land surveying, agriculture, defense, and logistics sectors, ZenaTech’s portfolio of solutions helps drive exceptional operational efficiencies, speed, and precision. The Company operates through global offices in North America, Europe, Taiwan, and UAE, and is growing its DaaS business and network of locations through acquisitions.About ZenaDrone&nbsp;&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=SGOzbSsHOOVhpTPv098iFfSo766gC4Kw2DIUCDGdApP98h2A9c55IvIIkIWmMSjQDN_seKVVUEJnlsxZVtdnsQ==">ZenaDrone</a>, a wholly owned subsidiary of ZenaTech, develops and manufactures autonomous business drone solutions that can incorporate machine learning software, AI, predictive modeling, Quantum Computing, and other software and hardware innovations. Created to revolutionize the hemp farming sector, its specialization has grown to multifunctional drone solutions for industrial surveillance, monitoring, inspection, tracking, process automation, and defense applications. Currently, the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=SGOzbSsHOOVhpTPv098iFYr0nrSQh9nEsc0_hmfB-vZiHYkSzMlOsFh2dJBcjoScz0cphG9lZKHK7E9PLkIP5t78PBbBdMxnhG4fKU9MiIxQEOpVqw-ADTh1aegPnIbC">ZenaDrone 1000</a> drone is used for crop management applications in agriculture and has been used critical field cargo applications in the defense sector, the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=95PeVMlLET_u0nagOWJk8k1OtR5pWGPW5lxOCAUzMAbc8QVJiQ-F5Tz7pd5E0H-62dv7w8pZk8jTEswIDXrdhIuD9gLeEV4BiWzbAtmKQfMUf0mbpakFP4hbWoOsNm4S">IQ Nano</a> indoor drone is used for inventory management and security in the warehouse and logistics sectors, and the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=bvc7AG5OFS_NuDEizJi9pNIseZiazRPCbiPKboYLiSh32qKb7mLKA74x5DpiAX7xbhaHjZseLAhj1BDKnngjjLGB4CgftB0b5hcn705ARmzUoKAqFf-0tRuYPyxf5sKh">IQ Square</a> is an outdoor drone designed for land surveys and inspections use in commercial and defense sectors.Contacts for more information:Company, Investors, and Media:Linda MontgomeryZenaTech312-241-1415<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=sZ-BmyP_kNDxApRNUydDwFGuACwVQ2LCbZ05u3FmeA85YYEIhycUBh9RifvGldveq6Koboto5LzV7KKSPiOMDOnzS-tZ9ABIs0BURYImeig=">investors@zenatech.com</a>Investors:Michael MasonCORE IR<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=sZ-BmyP_kNDxApRNUydDwFGuACwVQ2LCbZ05u3FmeA-qLis0CcVHhAgFfHiXb5U9P5as8l7nmfsCAlarUSuWIRYdYOx2EHKDjnIRqxQW9Xo=">investors@zenatech.com</a>Safe HarborThis press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. &nbsp;Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech's ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000, IQ Square and IQ Nano; ZenaTech's ability to develop products for markets as currently contemplated; ZenaTech’s anticipated cash needs and it’s needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months; ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of ZenaTech and other related risks ‎‎‎and uncertainties disclosed under the ‎heading “Risk Factors“ ‎‎‎‎in the Company’s Form F-1, Form 20-F and other filings filed ‎‎‎with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=-N2CmPify4rR_fu7Xx2JJr78uQbCWHdct-tv2uDnS7sTZTPZqZpAYhBczto6b7oKkWwl1Myi690CJx4rPgjrIg==">www.sec.gov</a>. The Company undertakes ‎‎‎no obligation to update forward-‎looking ‎‎‎‎information except as required by applicable law. Such forward-‎‎‎looking information represents ‎‎‎‎‎managements’ best judgment based on information currently available. ‎‎‎No forward-looking ‎‎‎‎statement ‎can be guaranteed and actual future results may vary materially. ‎‎‎Accordingly, readers ‎‎‎‎are advised not to ‎place undue reliance on forward-looking statements or ‎‎‎information.‎Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector

ZenaTech acquired UK-based Casado Design to expand its Drone as a Service (DaaS) offerings into the telecom infrastructure sector.

NEW YORK – December 9, 2025 – Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://psyencebiomed.com/ceo-year-end-letter-to-shareholders">today released a year-end Letter</a> from Chief Executive Officer Jody Aufrichtig, summarizing the Company’s 2025 achievements and outlining its strategic vision for 2026.In his year-end letter to shareholders, Aufrichtig described 2025 as a “turning point” in which Psyence BioMed delivered clinical execution, strengthened global manufacturing ties, and positioned itself at the forefront of the convergence between nature-derived psychedelic therapeutics and longevity science.“We recruited and dosed our first patients in a Phase IIb study. Through a further investment in <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://psylabs.life/">PsyLabs</a> we secured our psychedelic compound supply chain and became the only listed company with an investment in sustainable Ibogaine at source in Africa. We commenced studies in the exciting field of Longevity and ended the year debt free with over USD $9 million in cash reserves.”<h3>Clinical Progress and Phase IIb Trial Momentum</h3>Psyence BioMed advanced its Phase IIb clinical trial evaluating psilocybin-assisted psychotherapy for the treatment of Adjustment Disorder in palliative care. Multiple patients were dosed across several Australian clinical sites, supported by a partnership with Southern Star Research, one of Australia’s leading clinical research organisations.<h3>Advancing Nature-Derived Manufacturing and Supply Chain Leadership</h3>The Company strengthened its vertical integration through a multi-million-dollar follow-on investment in PsyLabs, securing GMP compliant nature-derived psilocybin and ibogaine supply for current and future programs. Psyence BioMed also announced a breakthrough in high purity ibogaine production, reinforcing its manufacturing advantage.<h3>Regulatory Tailwinds in Australia</h3>Aufrichtig noted the importance of the Australian Therapeutic Goods Administration’s (TGA) public consultation on psilocybin-assisted therapy for existential distress in patients with life-limiting illness – a development closely aligned with the Company’s clinical trial. If approved, the amendment would enable supervised access through the Authorised Prescriber framework and expand the eligible prescriber group to include palliative-care specialists.<img style="height:auto;" src="https://psyencebiomed.com/wp-content/uploads/2024/02/2.jpg" alt="" srcset="https://psyencebiomed.com/wp-content/uploads/2024/02/2-200x70.jpg 200w, https://psyencebiomed.com/wp-content/uploads/2024/02/2-400x140.jpg 400w, https://psyencebiomed.com/wp-content/uploads/2024/02/2-600x210.jpg 600w, https://psyencebiomed.com/wp-content/uploads/2024/02/2-800x280.jpg 800w, https://psyencebiomed.com/wp-content/uploads/2024/02/2-1200x420.jpg 1200w, https://psyencebiomed.com/wp-content/uploads/2024/02/2.jpg 2000w" sizes="100vw" width="2000" height="700"><h3>A Unique Position in Longevity Science</h3>“Psyence BioMed is currently the only publicly listed psychedelics company investing meaningfully in longevity science,” said Aufrichtig. “Our focus is on the emotional, neurobiological, and existential dimensions of aging, and we believe psychedelic-assisted therapy will play a central role in improving healthspan – not just lifespan.”<h3>2026 Outlook</h3>The Company plans to accelerate enrollment in its Phase IIb clinical trial, expand its manufacturing footprint, pursue additional longevity-focused indications, and evaluate strategic partnership opportunities throughout 2026.The full CEO Letter is available <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://psyencebiomed.com/ceo-year-end-letter-to-shareholders/">here</a>.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://psyencebiomed.com/ceo-year-end-letter-to-shareholders/">CEO Letter 2025</a><h3>Forward Looking Statements</h3>This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations, and intentions with respect to future operations, products and services; and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “outlook” or words of similar meaning.Forward-looking statements in this communication include statements regarding the progress of the Phase IIb clinical trial, the expansion of the Company’s current and future programs, and the expansion of the Company’s manufacturing capabilities. These forward-looking statements are based on a number of assumptions, including the assumption that there will be no delays in the execution of the Phase IIb clinical trial implementation schedule, the Company will secure the necessary regulatory and other consents required to expand its current and future programs, and that the demand for psychedelic-assisted therapy will continue to increase. There can be no assurance that the Company will continue to maintain compliance with Nasdaq’s continued listing requirements. There are numerous risks and uncertainties that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.These risks and uncertainties include, among others: (i) delays in the execution of the Phase IIb trial; (ii) the ability of Psyence BioMed to maintain the listing of its common shares and warrants on Nasdaq; (iii) volatility in the price of the securities of Psyence BioMed due to a variety of factors, including the recent share consolidation, changes in the competitive and highly regulated industries in which Psyence BioMed operates, variations in performance across competitors, changes in laws and regulations affecting Psyence BioMed’s business and changes in Psyence BioMed’s capital structure. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s final prospectus (File No. 333-289285) filed with the Securities and Exchange Commission (the “SEC”) on November 3, 2025 and other documents filed by Psyence BioMed from time to time with the SEC.These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Actual results and future events could differ materially from those anticipated in such statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except as required by law, Psyence BioMed does not intend to update these forward-looking statements.The Company does not make any medical, treatment or health benefit claims about its proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceutical products. The efficacy of such products has not been confirmed by authorized clinical research. There is no assurance that the use of psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed. The Company has not conducted clinical trials for the use of the proposed products. Any references to quality, consistency, efficacy, and safety of potential products do not imply that the Company has verified such in clinical trials or that the Company will complete such trials. If the Company cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on the Company’s performance and operations.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

Psyence BioMed summarized its successful 2025 clinical and supply-chain efforts, positioning for trial expansion and longevity research in 2026.

Oct 16, 2025<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.gclglobalholdings.com/node/7496/pdf">PDF Version</a>SINGAPORE, Oct. 16, 2025 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=2x82fuw9VJJJUEmVAN2fWDg6Sw9x_hHfQqJsJpOVf6PeFHAHJ9luCzQxM0Y9xzy-rCntrWszP9D2Q1Z1OyIkt-bu85WVTdN0qL_2owTrCaLuvnkh2JyOizXfAq8iWslU">GCL Global Holdings Ltd</a> (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that it has entered into a non-binding Memorandum of Understanding (“MOU”) to acquire Madeviral, a Singapore-based full-service marketing agency specializing in gamer-focused marketing.Founded in 2016, Madeviral helps gaming brands create impactful game marketing strategies to reach gamers globally. Madeviral started as one of the pioneers of game influencer marketing in the Southeast Asian region and according to Madeviral, it currently has a network of over 40,000 gaming influencers around the world. Madeviral’s services include conducting multinational localised marketing campaigns, large scale in-person gaming events, and publisher press conferences, helping with game- focused creative production and design, and many more. Madeviral represented that it has supported the growth of hundreds of influencers/media/partners across the Southeast Asian region and GCL believes that Madeviral has helped develop the game marketing infrastructure that has redefined the region.Under the terms of the MOU:<ul><li>GCL will explore acquiring up to 51% of Madeviral’s equity interests.</li><li>The parties have agreed to a 60-day exclusivity period to complete due diligence and negotiate definitive agreements.</li><li>The closing of the transaction is subject to customary closing conditions, including satisfactory completion of due diligence, regulatory approvals and board approval. &nbsp;</li></ul>“Madeviral’s creator-first approach, operational depth and deep roots in gaming culture make it a strong fit for GCL’s desire to grow its media ecosystem,” said Sebastian Toke, Group CEO of GCL. “This proposed acquisition supports our strategy to scale original IP and deepen engagement across digital platforms.”“We’ve always believed that the most powerful game marketing starts with authentic stories from game companies that reject the status quo and dare to shape the gaming world through innovations and impeccable standards of creativity,” said Don Sim, CEO of Madeviral. “Partnering with GCL will give us the platform and resources to expand globally while staying true to the brands and gaming communities we serve.”If the transaction is consummated, Madeviral’s leadership team is expected to remain in place post-acquisition, continuing to push the boundaries of marketing execution, driving content innovation and brand partnerships under GCL Group.Further details will be disclosed upon execution of definitive agreements.About GCL Global HoldingsGCL Global Holdings Ltd. (“GCL”) is a holding company incorporated in the Cayman Islands (GCL together with its subsidiaries, the “GCL Group”). Through its operating subsidiaries, GCL Group unites people through its ecosystem of content and hardware in games and entertainment, enabling creators to deliver engaging experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market.Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content as well as multimedia peripherals to bridge cultures and reach a global audience by introducing Asian-developed IP across consoles, PCs, and streaming platforms. Learn more at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=TBWSBvkAopF2fKVQbPe-OzjopIdNjik-vK27XWNyr4Ca3DZJN0UJZ1dpd8yQkwRtDRZzlHNjIYTxsac2GQmKnBZiTlHu1CnzZXn2BryJW3KIUQThQ_efhz44_ZRAAWtS">https://www.gclglobalholdings.com/</a>About MadeviralMadeviral is a full-service creative marketing agency specializing in marketing by gamers, for gamers. Headquartered in Singapore with teams across Asia, and the Americas, Madeviral helps game publishers, consumer brands, and Web3 companies launch high-impact campaigns that resonate with gaming communities worldwide. With a network of over 40,000 influencers and having completed more than 750 successful game campaigns, Madeviral combines multinational local market expertise, bold creative strategy, and deep industry insight to excite fans and drive global engagement.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=AVX4uUwFiFCM83SUlvynKPPrc8ydJJwajY5Fryz3FLr1UOsM6K-hYv9fd4IF1l8uvdS1mAeezlpUeVyFbS65VFB_h9LFoG_WqRkD5lwGC1k="> https://www.madeviral.co/</a>Forward-Looking StatementsThis press release includes “forward-looking statements” made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, and may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may also include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the estimated implied enterprise value of GCL, GCL’s ability to scale and grow its business, the advantages and expected growth of GCL, and GCL’s ability to source and retain creative talent and publish games. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of GCL’s management and are not predictions of actual performance.These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements. Although GCL believes that it has a reasonable basis for each forward-looking statement contained in this press release, GCL cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. In addition, there are risks and uncertainties described in GCL’s annual report on Form 20-F, filed with the SEC on July 31, 2025, and other documents filed by GCL from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. GCL cannot assure you that the forward-looking statements in this press release will prove to be accurate. There may be additional risks that GCL presently knows or that GCL currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release represent the views of GCL as of the date of this press release. Subsequent events and developments may cause those views to change. However, while GCL may update these forward-looking statements in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of GCL as of any date subsequent to the date of this press release. Except as may be required by law, GCL does not undertake any duty to update these forward-looking statements.GCL Investor Relations:Crocker Coulson <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=E-9hTZwFk8V6hZxO9z210eQfjYu69IWdMAiDLCNXKxBM6VpTuolM-JUXjCauuJ-6vz4k1R6NUZw3o8ZdfwkowmNvOET8C2dkgI47fjNg-DoCXsHZ6FxY3QNNazs95zph">crocker.coulson@aummedia.org</a> (646) 652-7185Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

GCL Executes MOU to Acquire Madeviral, Aiming to Accelerate Global Growth in Game Marketing and Publishing Support

GCL signed an MOU to acquire a majority stake in Madeviral, a Singapore-based, gamer-focused marketing agency, to expand its media ecosystem.

Nov 25, 2025<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.gclglobalholdings.com/node/7521/pdf">PDF Version</a>SINGAPORE, Nov. 25, 2025 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=PPNNNCpMzX2WWvWonjI9QcI2aT53G-P2boSXJkI-eBUerV0JAF2glvd7lMmENeqhYof5b64nALogOLEiTGAk29h-2jvO9ZID0yDep9CvhuWhgERZouW14P8n2pPgS54w">GCL Global Holdings Ltd</a> (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today provided an update on management’s expectations for financial results for the fiscal year 2026, ending March 31, 2026. The Company’s anticipated results reflect its continued growth trajectory in the core consumer and gaming-adjacent verticals, underpinned by the integration of Ban Leong Technologies, including its established distribution footprint and the continued scaling of our digital publishing business.FY 2026 Financial Outlook<ul><li>Revenue is expected to exceed $240 million, an increase of $100 million over FY 2025.</li><li>Gross Profit is anticipated to exceed $30 million, an increase of $10 million over FY 2025.</li></ul>“FY 2026 is a critical year for GCL as we continue to develop our key game IPs like Showa American Story and The Defiant, which we believe have blockbuster potential in FY 2027 and beyond,” said Sebastian Toke, Group CEO of GCL. “Over the past several months, we’ve been focused on assembling the core components of a full-service gaming ecosystem spanning from publishing, distribution, hardware, to original IP creation. Bringing these capabilities together is an essential step toward unlocking the long-term value of our platform. The integration of Ban Leong into GCL Group is proceeding well and we expect to see synergies from the combination of game IP with a full suite of gaming hardware and peripherals.”“Asian gaming studios are producing a new wave of highly original potential triple-A titles with global appeal. With our proven track record in game publishing and distribution, GCL is well-positioned to leverage this macro trend. GCL is actively working on entering into new publishing arrangements and potential investments in gaming studios to strengthen our pipeline of high potential IPs. We believe these efforts will position us for meaningful, sustainable growth as these assets begin to operate as a unified engine.”The Company plans to release its financial results for the first half of FY2026 in December and will host an investor conference call in the morning of the release.About GCL Global HoldingsGCL Global Holdings Ltd. (“GCL”) is a holding company incorporated in the Cayman Islands (GCL together with its subsidiaries, the “GCL Group”). Through its operating subsidiaries, GCL Group unites people through its ecosystem of content and hardware in games and entertainment, enabling creators to deliver engaging experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market.Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content as well as multimedia peripherals to bridge cultures and reach a global audience by introducing Asian-developed IP across consoles, PCs, and streaming platforms. Learn more at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=j-sLVTzXUnOz2u28bwgrRfCOuE6W3CyOT3UaXqueQyssqTerFu9PccIAQrfpG13FtoJtRHyGgvZHenCCWT5bbS0ZEGyl17h8jsYTIvsq9XX6vACnTKa_sleYGgZ3CF9G">https://www.gclglobalholdings.com/</a>Forward-Looking StatementsThis press release includes “forward-looking statements” made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, and may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may also include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the estimated implied enterprise value of GCL, GCL’s ability to scale and grow its business, the advantages and expected growth of GCL, and GCL’s ability to source and retain creative talent and publish games. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of GCL’s management and are not predictions of actual performance.These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements. Although GCL believes that it has a reasonable basis for each forward-looking statement contained in this press release, GCL cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. In addition, there are risks and uncertainties described in GCL’s annual report on Form 20-F, filed with the SEC on July 31, 2025, and other documents filed by GCL from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. GCL cannot assure you that the forward-looking statements in this press release will prove to be accurate. There may be additional risks that GCL presently knows or that GCL currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release represent the views of GCL as of the date of this press release. Subsequent events and developments may cause those views to change. However, while GCL may update these forward-looking statements in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of GCL as of any date subsequent to the date of this press release. Except as may be required by law, GCL does not undertake any duty to update these forward-looking statements.GCL Investor Relations:Crocker Coulson <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=YGtaxaMkV-ObQQIXcJdLEUck_G4VzW6JzVcBV87-eLPvqCMUrQg4EY_wjfz7sqHKiiC6ujPwhuPT0K_8iMjyhoNodrPaNADvc15Uex3CT0vDsmR_0e0GT86GuvZku9Vi">crocker.coulson@aummedia.org</a> (646) 652-7185Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

GCL Announces Fiscal Year 2026 Revenue and Gross Profit Expectations

GCL Global Holdings Ltd. anticipates over $240 million in revenue and over $30 million in gross profit for fiscal year 2026, driven by growth in its core business and the integration of Ban Leong Technologies.

November 3, 2025TOKYO, Nov. 3, 2025 /PRNewswire/ -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.toyo-solar.com/">TOYO Co., Ltd</a> (Nasdaq: TOYO) (OTC: TOYWF), ("TOYO" or the "Company"), a solar solution company, today announced it has officially entered into a strategic partnership with Voltec Solar, a photovoltaic panel manufacturer based in France, marking TOYO's entry into the European market and accelerating its global expansion toward low-carbon solar infrastructure.The signing ceremony took place at TOYO's production base in Vietnam, where TOYO's management was joined by Erick Valdez, Chief Operating Officer of Voltec Solar, Thomas Regrettier, Chief Technology Officer of Voltec Solar and Hironori Tokumoto of Abalance Group, the parent company of TOYO.Under the agreement, TOYO will become Voltec Solar's official solar cell supplier. The partnership leverages TOYO's high-performance, low-carbon cell technology, which has enabled Voltec Solar to obtain a carbon footprint certification from Certisolis, a French laboratory specializing in photovoltaic solar panel testing."Partnering with TOYO allows us to integrate high-efficiency, low-carbon solar cells into our production line while meeting Europe's strict sustainability standards," said Erick Valdez, COO of Voltec Solar. "This collaboration strengthens our supply chain and supports our mission to deliver certified, climate-aligned solar solutions across Europe.""This partnership marks an exciting step forward for TOYO to enter the European market," said Junsei Ryu, Chairman and CEO of TOYO. "It underscores our commitment to a cleaner, greener future. We look forward to bringing high-quality, low-carbon solar solutions to Europe and beyond."This collaboration reflects both companies' shared commitment to innovation, sustainability and alignment with the EU Net-Zero Industry Act. It also demonstrates TOYO's readiness to integrate into global supply chains and support European manufacturers seeking certified, climate-aligned solar technologies.About TOYO Co., Ltd.TOYO is a solar solutions company committed to becoming a full-service solar solutions provider in the global market, integrating upstream production of wafers and silicon, midstream production of solar cells, downstream production of photovoltaic modules, and potentially other stages of the solar power supply chain. TOYO is well-positioned to produce high-quality solar cells at a competitive scale and cost.About Voltec SolarFounded in 2010 and based in France, Voltec Solar is a manufacturer of high-performance photovoltaic panels. With a strong focus on innovation and sustainability, the company operates advanced production lines compatible with next-generation solar technologies, including TOPCon and heterojunction cells. Voltec Solar is committed to delivering certified, low-carbon solar solutions across Europe and beyond.Forward-Looking StatementsStatements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "look forward to," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the section entitled "Risk Factors" in TOYO's annual report on Form 20-F, as well as discussions of potential risks, uncertainties, and other important factors in TOYO's subsequent filings with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof. TOYO specifically disclaims any obligation to update any forward-looking statement, whether due to new information, future events, or otherwise. Readers should not rely upon the information on this page as current or accurate after its publication date.Contact Information:For TOYO Co., Ltd. <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:IR@toyo-solar.com">IR@toyo-solar.com&nbsp;</a>&nbsp;Crocker Coulson Email: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:crocker.coulson@aummedia.org">crocker.coulson@aummedia.org</a> Tel: (646) 652-7185<img src="https://edge.prnewswire.com/c/img/favicon.png?sn=CN13688&amp;sd=2025-11-03" alt="Cision" width="12" height="12"> View original content:<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/toyo-and-voltec-solar-forge-strategic-partnership-to-deliver-low-carbon-solar-solutions-across-europe-302602472.html">https://www.prnewswire.com/news-releases/toyo-and-voltec-solar-forge-strategic-partnership-to-deliver-low-carbon-solar-solutions-across-europe-302602472.html</a>SOURCE TOYO Co., LtdNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

TOYO Co., Ltd. has partnered with Voltec Solar to become its solar cell supplier, marking TOYO's entry into the European market with low-carbon solar solutions.

Dec 2, 2025<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.gclglobalholdings.com/node/7561/pdf">PDF Version</a>SINGAPORE, Dec. 02, 2025 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=vps3SC_3dUCuFlJyV5CA-7F8vimATo8lKKZdAC1A5GL5vsr8zRFkOaXf56-jiv6sNj-7fAhNQ2VVjYF2KZRHXBab2jtqD0kjEDQ5OumhryXFDhyfWfpLHkgS65ZhyhV8">GCL Global Holdings Ltd</a> (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that its publishing subsidiary, 4Divinity Pte. Ltd. (“4Divinity”), has received a $3.0 million strategic investment from ADATA Technology Co. Ltd. (“ADATA”), a global leader in memory and storage solutions listed on the Taipei Exchange (TPEX), for approximately 1.2% equity interests of 4Divinity.Founded in 2001, ADATA is the world’s second-largest manufacturer of DRAM memory and SSDs. In addition to its core products, its XPG gaming division provides high-performance systems, components, and peripherals for gamers and esports professionals, earning global design awards. The investment offers the potential for partnership and synergies through tie-ins such as memory cards and gaming products that can be customized with game IP.Simon Chen, Chairman and CEO of ADATA, stated that, “We are thrilled to formalize our collaboration with 4Divinity by becoming its strategic shareholder. We believe that the gaming titles that 4Divinity has in its pipeline have true blockbuster potential and its strong creative and operational leadership made this an easy decision for us. We look forward to playing a part in shaping the future of interactive entertainment.”“We are honored to welcome one of the world’s most respected leaders in memory and storage technology as a strategic shareholder,” said Sebastian Toke, Group CEO of GCL. “This investment is a strong testament to the reputation 4Divinity has built in the global gaming industry and further reinforces our brand as a trusted and ambitious partner in next-generation entertainment. The collaboration further enhances our end-to-end ecosystem as we prepare to bring highly anticipated titles such as ‘Showa American Story’ and ‘The Defiant’ to market through our 4Divinity publishing arm. We look forward to exploring broader collaboration opportunities that leverage both parties’ strengths across gaming, infrastructure, and immersive digital entertainment.”About GCL Global HoldingsGCL Global Holdings Ltd. (“GCL”) is a holding company incorporated in the Cayman Islands (GCL together with its subsidiaries, the “GCL Group”). Through its operating subsidiaries, GCL Group unites people through its ecosystem of content and hardware in games and entertainment, enabling creators to deliver engaging experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market.Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content as well as multimedia peripherals to bridge cultures and reach a global audience by introducing Asian-developed IP across consoles, PCs, and streaming platforms. Learn more at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=ZSwwpHSj6P8Wk1FtMb0FH_QHKNcEBoxLheM8p7eP91j-cLKG-yhtCQVoy82L53WkPaCiHeFKe6Wf5JIrsY_eXa2sWSNpLU7agxuGki_voQND2aVzYGFxUhs6JHZj9e3G">https://www.gclglobalholdings.com/</a>About 4Divinity4Divinity is a digital and retail games publishing company and a wholly owned subsidiary of GCL, focused on bringing exciting game content from around the world to Asia and introducing Asian content to a global market. Along with its sister company, Epicsoft Asia, 4Divinity is partnering with publishers and development studios to introduce brand-new IP to the region. <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=ZSwwpHSj6P8Wk1FtMb0FHyGKlVyy2ii7eUb8N8Bz2UBT609aOWnY_SD4fBiQzK66Iaib0zOv0RFK2EJYdl3hITplN4ubEzgtVFLY88us25I=">https://www.4divinity.com/</a>About ADATA – Innovating the FutureADATA Technology is the world's second-largest manufacturer of DRAM memory and branded solid state drives, ranked top 25 among Best Taiwan Global Brands. ADATA's main product lines include memory modules, solid state drives, consumer electronics, and industrial solutions. The company has also expanded into enterprise storage under the TRUSTA brand, AI AMR robots, electric vehicles, and gaming products through its XPG brand. ADATA’s products have garnered wide international acclaim over the years including iF Design, Red Dot Design, and Taiwan Excellence awards. Looking to the future, ADATA remains committed to its sustainable vision of “Innovate Today, Embrace Tomorrow.” The company continues to embody the “hummingbird spirit” as it uses innovative technology to create a smart and colorful life for people everywhere. For more information, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=4aFrGxG7rv2P4tAdt5wYC9e5qCNjzw0ryYsVGNe__flew1T7aXukn18ap0QdvLY1b9WhBr6YaJuEE8ifjbulkQ==">www.adata.com</a>. &nbsp;Forward-Looking StatementsThis press release includes “forward-looking statements” made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, and may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may also include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the estimated implied enterprise value of GCL, GCL’s ability to scale and grow its business, the advantages and expected growth of GCL, and GCL’s ability to source and retain creative talent and publish games. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of GCL’s management and are not predictions of actual performance.These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements. Although GCL believes that it has a reasonable basis for each forward-looking statement contained in this press release, GCL cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. In addition, there are risks and uncertainties described in GCL’s annual report on Form 20-F, filed with the SEC on July 31, 2025, and other documents filed by GCL from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. GCL cannot assure you that the forward-looking statements in this press release will prove to be accurate. There may be additional risks that GCL presently knows or that GCL currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release represent the views of GCL as of the date of this press release. Subsequent events and developments may cause those views to change. However, while GCL may update these forward-looking statements in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of GCL as of any date subsequent to the date of this press release. Except as may be required by law, GCL does not undertake any duty to update these forward-looking statements.GCL Investor Relations:Crocker Coulson <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=ZTSyQ0sVbY4Ns0jSqMP-Cq8ajWPSnEsgWR34juefWXJNaunUEkpfjwGpeSWBLlUTV_aQHYFKpYqjOzDm3n6hw7pfLtVhsaL98E5YC2WnamVpD55_KxPicp41Iq04rn2J">crocker.coulson@aummedia.org</a> (646) 652-7185Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

GCL Announces $3 Million Strategic Investment in Publishing Subsidiary, 4Divinity, by ADATA Technology

GCL Global Holdings announced that its publishing subsidiary, 4Divinity, received a $3.0 million strategic investment from ADATA Technology for a 1.2% equity interest.